Hi Frank, I called my German online bank/broker earlier

New Post Public Reply Private Reply Replies (1) Message Board
Zolis_onkel franksullivan #14318
468
Hi Frank,

I called my German online bank/broker earlier today and asked them about the 1:4 dividend. They explicitely checked for me while I am on the phone with them and assured me that they do not have an related official information. When I asked them to investigate about it for me, they referred me to GNBT or its trading agent and asked me to find it out myself ("great" service that they provide to their customers, isn't it!?).
So I sent them the following email just now (everybody welcome to use it, if needed, just exchange the numbers (that I XXXed out) and dates accordingly):

Dear ladies and gents,

I am a longterm shareholder of GNBT from Germany. As that I was a beneficiary of several share dividends that GNBT has given out in recent years.
I have received the extra GNBT shares in both related dividends (the 20:1 and the 2:5), however, so far the dividends involving shares of GNBT's subsidiary Antigen Express/NGIO were missing. In this regard, I contacted GNBT's investor relations manager, Todd Falls, in March of 2019 and again recently, and he suggested to be patient and wait for the IPO of NGIO to happen and in due time before this spin-out, I can be rest assured that these shares will be paid out to me, even here in Germany.

During this past week (effective date March, 11th); I now have received the Antigen Express shares from the most recent 2:5 dividend (pay date, February 24th 2020). What I am still missing are the Antigen Express/NGIO shares from the 1:4 dividend with a pay date of February, 25th 2019.
So I first contacted my German online broker (Deutsche Kredit Bank (DKB)), only to receive the information that they never received any notice about the 1:4 dividend. They  referred me to you, as the trading agent for GNBT, to request that you'd officially send the appropriate information and related number of shares such that they can re-distribute them into my brokerage account.
On the related record date for the 1:4 NGIO dividend, a little over a year ago, I held XX,XXX GNBT shares and thus I am elgible to receive XX,XXX shares of Antigen Express/NGIO. May I ask you to take whatever necessary action such that I can get those dividend shares that I am eligible for?
Many thanks in advance for your help and assistance in this matter.

Best regards from Germany,

XXXXX

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 22

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 15

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 19

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 24

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 11

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 23

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Excitement Builds for the 2025 Special Olympics Winter Games

Updated Category News Views 612

The Opening Ceremony of the 2025 Special Olympics World Winter Games In a grand celebration last night, the lights illuminated the Inalpi Arena, marking the commencement of the 2025 Special Olympics World Winter Games in Turin. This event is poised to become the largest sports and humanitarian gathering of the year. With the lighting of the "Flame of Hope," over 1,500...

Continue Reading
Embracing Pet Ownership: Older Canadians Thrive with Pets

Updated Category News Views 173

Discover the Joy of Pet Ownership Among Older Canadians Pet ownership can transform lives, and for older Canadians, the companionship of a furry friend offers numerous emotional and physical benefits. According to a recent survey by Ipsos for HomeEquity Bank, it has become evident that many Canadians aged 55 and over understand the significant value of sharing their lives...

Continue Reading
Salus Scientific: A Solid Stand Against Industry Recalls Risk

Updated Category News Views 283

Reputation on the Line Nothing shakes the confidence of hospitals like a recall. You know how it is—one day, everything's rolling along fine, and then BAM, safety issues pop up like bad news at a family dinner. Take Salus Scientific, for instance. They’re standing firm against the wave of issues unraveling other companies in radiation protection gear. They’ve got a...

Continue Reading
Investigation into Potential Violations of Securities Laws

Updated Category News Views 276

Investigation into Potential Violations of Securities Laws Halper Sadeh LLC, a dedicated investor rights law firm, has launched an investigation into several companies regarding potential breaches of fiduciary duties and violations of federal securities laws. This initiative particularly aims to benefit shareholders of Old Point Financial Corporation, ProAssurance...

Continue Reading
Concerns Rise Over Fluoride in Children's Oral Products

Updated Category News Views 150

Lawsuits Target Leading Oral Health Brands Recent legal troubles have emerged for Procter & Gamble and Colgate-Palmolive regarding their children's oral care products. Parents are voicing their concerns through multiple lawsuits against these industry giants, claiming that fluoride in toothpaste and mouth rinses poses health risks for young children. Key Products Under...

Continue Reading